UBS’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$39.8M Buy
373,339
+246,439
+194% +$25.6M 0.03% 604
2014
Q2
$13.3M Sell
126,900
-34,408
-21% -$3.48M 0.01% 1146
2014
Q1
$15.8M Sell
161,308
-110,192
-41% -$10.2M 0.01% 937
2013
Q4
$24.9M Buy
271,500
+22,100
+9% +$2.04M 0.02% 685
2013
Q3
$21.6M Sell
249,400
-22,800
-8% -$2.05M 0.02% 675
2013
Q2
$23.4M Buy
+272,200
New +$23.1M 0.03% 578

Other funds holding JNJ

UBS's JNJ Position: Q3 2014 in Review

UBS increased its Johnson & Johnson (JNJ) stake by 7.2% in Q3 2014, buying an estimated $77.3M and bringing the position to 11,028,066 shares worth $1.18B. The position accounts for 0.87% of the portfolio, ranked #6.

UBS first reported a position in JNJ in Q2 2013 and has held it in 6 quarters since. 1,987 funds tracked by Wall St. Rank hold JNJ as of Q3 2014.

  • UBS held 11,028,066 shares of Johnson & Johnson worth $1.18B as of Q3 2014.
  • UBS bought 745,285 Johnson & Johnson shares in Q3 2014, an estimated $77.3M.
  • Johnson & Johnson made up 0.87% of UBS's portfolio in Q3 2014, its #6 holding.
  • UBS first reported a position in Johnson & Johnson in Q2 2013 and has held it in 6 quarters since.
  • 1,987 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.